• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Renin-angiotensin system and progression of chronic liver diseases.

作者信息

Yoshiji Hitoshi, Fukui Hiroshi

出版信息

J Gastroenterol. 2006 Oct;41(10):1020-2. doi: 10.1007/s00535-006-1897-8.

DOI:10.1007/s00535-006-1897-8
PMID:17096072
Abstract
摘要

相似文献

1
Renin-angiotensin system and progression of chronic liver diseases.肾素-血管紧张素系统与慢性肝病的进展
J Gastroenterol. 2006 Oct;41(10):1020-2. doi: 10.1007/s00535-006-1897-8.
2
Possible involvement of angiogenesis in chronic liver diseases: interaction among renin-angiotensin-aldosterone system, insulin resistance and oxidative stress.可能参与慢性肝病的血管生成：肾素-血管紧张素-醛固酮系统、胰岛素抵抗和氧化应激之间的相互作用。
Curr Med Chem. 2012;19(12):1889-98. doi: 10.2174/092986712800099848.
3
Pathways of hepatic and renal damage through non-classical activation of the renin-angiotensin system in chronic liver disease.慢性肝病中非经典肾素-血管紧张素系统激活导致的肝肾功能损伤途径。
Liver Int. 2020 Jan;40(1):18-31. doi: 10.1111/liv.14272. Epub 2019 Nov 4.
4
Does the intrarenal reactive oxygen species/angiotensinogen/renin-Angiotensin system axis play an important role in the progression of chronic kidney disease?
Clin Exp Pharmacol Physiol. 2009 Aug;36(8):748-9. doi: 10.1111/j.1440-1681.2009.05218.x. Epub 2009 May 19.
5
The impact of stopping inhibitors of the renin-angiotensin system in patients with advanced chronic kidney disease.停止应用肾素-血管紧张素系统抑制剂对晚期慢性肾脏病患者的影响。
Nephrol Dial Transplant. 2010 Dec;25(12):3977-82. doi: 10.1093/ndt/gfp511. Epub 2009 Oct 10.
6
Renin-angiotensin inhibitors in stage 4 chronic kidney disease.
Kidney Int. 2006 Nov;70(10):1880; author reply 1880-1. doi: 10.1038/sj.ki.5001837.
7
The role of renin-angiotensin-aldosterone system in the progression of chronic kidney disease.肾素-血管紧张素-醛固酮系统在慢性肾脏病进展中的作用
Kidney Int Suppl. 2005 Dec(99):S57-65. doi: 10.1111/j.1523-1755.2005.09911.x.
8
[Effect of chronic liver diseases on the endocrine system].[慢性肝病对内分泌系统的影响]
Z Arztl Fortbild (Jena). 1983;77(10):415-8.
9
Sex and the renin angiotensin system: implications for gender differences in the progression of kidney disease.性别与肾素血管紧张素系统：对肾脏疾病进展中性别差异的影响。
Adv Ren Replace Ther. 2003 Jan;10(1):15-23. doi: 10.1053/jarr.2003.50006.
10
Activated tissue renin-angiotensin systems add to the progression of heart failure.激活的组织肾素-血管紧张素系统会加重心力衰竭的进展。
Basic Res Cardiol. 1996;91 Suppl 2:85-90. doi: 10.1007/BF00795368.

引用本文的文献

1
Antiangiogenic Drugs in NASH: Evidence of a Possible New Therapeutic Approach.非酒精性脂肪性肝炎中的抗血管生成药物：一种可能的新治疗方法的证据
Pharmaceuticals (Basel). 2021 Sep 29;14(10):995. doi: 10.3390/ph14100995.
2
Medications in type-2 diabetics and their association with liver fibrosis.2 型糖尿病患者的药物治疗及其与肝纤维化的关系。
World J Gastroenterol. 2020 Jun 21;26(23):3249-3259. doi: 10.3748/wjg.v26.i23.3249.
3
Attrition of Hepatic Damage Inflicted by Angiotensin II with α-Tocopherol and β-Carotene in Experimental Apolipoprotein E Knock-out Mice.

本文引用的文献

1
Preventive and therapeutic effects of angiotensin II type 1 receptor blocker on hepatic fibrosis induced by bile duct ligation in rats.血管紧张素II 1型受体阻滞剂对大鼠胆管结扎所致肝纤维化的防治作用
J Gastroenterol. 2006 Oct;41(10):996-1004. doi: 10.1007/s00535-006-1891-1. Epub 2006 Nov 9.
2
Angiotensin-II and vascular endothelial growth factor interaction plays an important role in rat liver fibrosis development.血管紧张素 II 和血管内皮生长因子相互作用在大鼠肝纤维化发展中起重要作用。
Hepatol Res. 2006 Oct;36(2):124-9. doi: 10.1016/j.hepres.2006.07.003. Epub 2006 Aug 17.
3
Angiogenesis in life, disease and medicine.
α-生育酚与β-胡萝卜素对实验性载脂蛋白E基因敲除小鼠中血管紧张素II所致肝损伤的减轻作用
Sci Rep. 2015 Dec 16;5:18300. doi: 10.1038/srep18300.
4
The renin-angiotensin system and hypertension in autosomal recessive polycystic kidney disease.常染色体隐性多囊肾病中的肾素-血管紧张素系统与高血压。
Pediatr Nephrol. 2010 Dec;25(12):2449-57. doi: 10.1007/s00467-010-1621-z. Epub 2010 Aug 27.
5
The effect of angiotensin-blocking agents on liver fibrosis in patients with hepatitis C.血管紧张素阻断剂对丙型肝炎患者肝纤维化的影响。
Liver Int. 2009 May;29(5):748-53. doi: 10.1111/j.1478-3231.2009.01973.x. Epub 2009 Feb 9.
生命、疾病与医学中的血管生成
Nature. 2005 Dec 15;438(7070):932-6. doi: 10.1038/nature04478.
4
Liver fibrogenesis: a new role for the renin-angiotensin system.肝纤维化形成：肾素-血管紧张素系统的新作用
Antioxid Redox Signal. 2005 Sep-Oct;7(9-10):1346-55. doi: 10.1089/ars.2005.7.1346.
5
Suppression of renin-angiotensin system attenuates hepatocarcinogenesis via angiogenesis inhibition in rats.抑制肾素-血管紧张素系统通过抑制大鼠血管生成减轻肝癌发生。
Anticancer Res. 2005 Sep-Oct;25(5):3335-40.
6
Attenuated hepatic inflammation and fibrosis in angiotensin type 1a receptor deficient mice.1a型血管紧张素受体缺陷小鼠肝脏炎症和纤维化减轻
J Hepatol. 2005 Aug;43(2):317-23. doi: 10.1016/j.jhep.2005.02.034.
7
Expression of angiotensin II type 1 receptor in human cirrhotic livers: Its relation to fibrosis and portal hypertension.血管紧张素 II 型 1 型受体在人肝硬化肝脏中的表达：与纤维化和门脉高压的关系。
Hepatol Res. 2005 Jun;32(2):107-16. doi: 10.1016/j.hepres.2005.01.017.
8
Combination of vitamin K2 and the angiotensin-converting enzyme inhibitor, perindopril, attenuates the liver enzyme-altered preneoplastic lesions in rats via angiogenesis suppression.维生素K2与血管紧张素转换酶抑制剂培哚普利联合使用，通过抑制血管生成减轻大鼠肝脏酶改变的癌前病变。
J Hepatol. 2005 May;42(5):687-93. doi: 10.1016/j.jhep.2004.12.025.
9
Combination of interferon-beta and angiotensin-converting enzyme inhibitor, perindopril, attenuates the murine liver fibrosis development.β-干扰素与血管紧张素转换酶抑制剂培哚普利联合使用可减轻小鼠肝纤维化的发展。
Liver Int. 2005 Feb;25(1):153-61. doi: 10.1111/j.1478-3231.2005.01038.x.
10
Imatinib mesylate (STI-571) attenuates liver fibrosis development in rats.甲磺酸伊马替尼（STI-571）可减轻大鼠肝纤维化的发展。
Am J Physiol Gastrointest Liver Physiol. 2005 May;288(5):G907-13. doi: 10.1152/ajpgi.00420.2004. Epub 2004 Dec 23.